Skip to content
10-K

Annual Report

Galera Therapeutics, Inc. GRTX

0001563577-26-000005

← back to feed
Filed
Mar 19, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 16, 2026 75.46M sh
Shares Diluted FY 2025 · Dec 31, 2025 98.5M sh
Shares Diluted FY 2025 · Dec 31, 2024 54.63M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$6.05M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$12.15M
Cash And Equivalents FY 2025 · Dec 31, 2025 $6.38M
Cash And Equivalents FY 2025 · Dec 31, 2024 $8.29M
Stockholders Equity FY 2025 · Dec 31, 2025 $3.97M
Stockholders Equity FY 2025 · Dec 31, 2024 −$148.04M
Stockholders Equity FY 2025 · Dec 31, 2023 −$131.19M
Current Liabilities FY 2025 · Dec 31, 2025 $645K
Current Liabilities FY 2025 · Dec 31, 2024 $1.67M
Total Liabilities FY 2025 · Dec 31, 2025 $645K
Total Liabilities FY 2025 · Dec 31, 2024 $153.77M
Current Assets FY 2025 · Dec 31, 2025 $7.1M
Current Assets FY 2025 · Dec 31, 2024 $10M
Total Assets FY 2025 · Dec 31, 2025 $7.2M
Total Assets FY 2025 · Dec 31, 2024 $10.1M
Eps Diluted FY 2025 · Dec 31, 2025 $0.64
Eps Diluted FY 2025 · Dec 31, 2024 −$0.34
Eps Basic FY 2025 · Dec 31, 2025 $0.64
Eps Basic FY 2025 · Dec 31, 2024 −$0.34
Sga Expense FY 2025 · Dec 31, 2025 $5.69M
Sga Expense FY 2025 · Dec 31, 2024 $11M
Rd Expense FY 2025 · Dec 31, 2025 $349K
Rd Expense FY 2025 · Dec 31, 2024 $3.15M
Net Income FY 2025 · Dec 31, 2025 $149.05M
Net Income FY 2025 · Dec 31, 2024 −$18.96M
Operating Income FY 2025 · Dec 31, 2025 −$2.54M
Operating Income FY 2025 · Dec 31, 2024 −$20.16M
Stock Issued FY 2025 · Dec 30, 2024 21.07M sh